Skip to main content
. 2014 Nov;52(11):3933–3943. doi: 10.1128/JCM.02411-14

TABLE 3.

Prevalences of marker alleles

Presence/allele (accession no. or strain) Code no. Prevalences for isolates by type:
Total
Human, Germany
Human, Trinidad and Tobago
Veterinary, Germany
Human, invasive infection
Human, localized infection
Human, carriage
No. % No. % No. % No. % No. % No. % No. %
bac negative B-0 384 85,7 327 85.2 34 100.0 16 76.2 100 87.0 42 87.5 219 85.9
bac positive B-1 64 14.3 57 14.8 0 0.0 5 23.8 15 13.0 6 12.5 36 14.1
alp negative A-0 3 0.7 2 0.5 0 0.0 1 4.8 1 0.9 1 2.1 0 0.0
alp-2 A-2 25 5.6 23 6.0 0 0.0 1 4.8 4 3.5 9 18.8 10 3.9
alp-3 A-3 67 15.0 61 15.9 2 5.9 3 14.3 19 16.5 9 18.8 35 13.7
alp-4 A-4 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
alp-5 A-5 86 19.2 70 18.2 3 8.8 11 52.4 20 17.4 8 16.7 45 17.6
alp-bca A-B 89 19.9 66 17.2 16 47.1 5 23.8 18 15.7 6 12.5 58 22.7
alp-R2 A-R2 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
alp-rib (R4) A-R4 177 39.5 161 41.9 13 38.2 0 0.0 53 46.1 15 31.3 106 41.6
alp atypical/unidentified A-X 1 0.2 1 0.3 0 0.0 0 0.0 0 0.0 0 0.0 1 0.4
pil1 negative P1-0 120 26.8 83 21.6 24 70.6 10 47.6 24 20.9 9 18.8 74 29.0
pil1A/C P1–2 4 0.9 2 0.5 0 0.0 2 9.5 0 0.0 0 0.0 2 0.8
pil1A/B/C P1–3 320 71.4 296 77.1 10 29.4 8 38.1 89 77.4 39 81.3 178 69.8
pil1 atypical/unidentified P1-X 4 0.9 3 0.8 0 0.0 1 4.8 2 1.7 0 0.0 1 0.4
pepS8 negative E-0 118 26.3 95 24.7 17 50.0 3 14.3 29 25.2 16 33.3 67 26.3
pepS8 positive E-1 330 73.7 289 75.3 17 50.0 18 85.7 86 74.8 32 66.7 188 73.7
fbsB (AM050623) F-3 12 2.7 5 1.3 0 0.0 7 33.3 0 0.0 1 2.1 4 1.6
fbsB (AM050624) F-4 2 0.4 2 0.5 0 0.0 0 0.0 1 0.9 1 2.1 0 0.0
fbsB (515) F-5 187 41.7 155 40.4 26 76.5 2 9.5 61 53.0 22 45.8 98 38.4
fbsB (AY326423) F-6 7 1.6 7 1.8 0 0.0 0 0.0 1 0.9 0 0.0 6 2.4
fbsB (A909) F-9 240 53.6 215 56.0 8 23.5 12 57.1 52 45.2 24 50.0 147 57.6
Capsule type:
    Ia C-1A 107 23.9 80 20.8 17 50.0 7 33.3 25 21.7 14 29.2 58 22.7
    Ib C-1B 26 5.8 23 6.0 0 0.0 2 9.5 10 8.7 0 0.0 13 5.1
    II C-2 64 14.3 57 14.8 4 11.8 2 9.5 11 9.6 4 8.3 46 18.0
    III C-3 137 30.6 129 33.6 3 8.8 3 14.3 47 40.9 14 29.2 71 27.8
    IV C-4 20 4.5 11 2.9 6 17.6 3 14.3 1 0.9 4 8.3 12 4.7
    V C-5 88 19.6 79 20.6 3 8.8 4 19.0 21 18.3 11 22.9 50 19.6
    VI C-6 1 0.2 1 0.3 0 0.0 0 0.0 0 0.0 0 0.0 1 0.4
    VII C-7 1 0.2 1 0.3 0 0.0 0 0.0 0 0.0 0 0.0 1 0.4
    VIII C-8 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
    IX C-9 3 0.7 3 0.8 0 0.0 0 0.0 0 0.0 1 2.1 2 0.8
No capsule/truncated cap locus C-0 1 0.2 0 0.0 1 2.9 0 0.0 0 0.0 0 0.0 1 0.4
hylB negative H-0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
hylB (NEM316) H-3 401 89.5 348 90.6 34 100.0 12 57.1 102 88.7 46 95.8 234 91.8
hylB (A909) H-9 47 10.5 36 9.4 0 0.0 9 42.9 13 11.3 2 4.2 21 8.2
abiG/Q8DZ34 negative Q-0 309 69.0 261 68.0 28 82.4 15 71.4 92 80.0 28 58.3 169 66.3
abiG/Q8DZ34 (NEM316) Q-3 36 8.0 34 8.9 0 0.0 1 4.8 4 3.5 10 20.8 20 7.8
abiG/Q8DZ34 (H36B) Q-6 101 22.5 87 22.7 6 17.6 5 23.8 17 14.8 10 20.8 66 25.9
abiG/Q8DZ34 (unidentified) Q-X 2 0.4 2 0.5 0 0.0 0 0.0 2 1.7 0 0.0 0 0.0
pil2 negative P2-0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
pil2a (18RS21) P2-A1 104 23.2 96 25.0 5 14.7 1 4.8 19 16.5 9 18.8 73 28.6
pil2a (NEM316) P2-A3 115 25.7 105 27.3 2 5.9 6 28.6 32 27.8 13 27.1 62 24.3
pil2a (ABC020013424) P2-A4 7 1.6 7 1.8 0 0.0 0 0.0 1 0.9 3 6.3 3 1.2
pil2a (515) P2-A5 88 19.6 67 17.4 17 50.0 2 9.5 24 20.9 7 14.6 53 20.8
pil2a (H36B) P2-A6 1 0.2 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
pil2a (ABC020016680) P2-A8 18 4.0 17 4.4 0 0.0 1 4.8 2 1.7 8 16.7 7 2.7
pil2a (ABC020005369) P2-A9 11 2.5 10 2.6 0 0.0 1 4.8 2 1.7 1 2.1 7 2.7
pil2a (unidentified) P2-AX 6 1.3 5 1.3 1 2.9 0 0.0 2 1.7 0 0.0 4 1.6
pil2b (COH1) P2-B1 79 17.6 69 18.0 9 26.5 0 0.0 33 28.7 7 14.6 38 14.9
pil2b (527.25) P2-B5 8 1.8 2 0.5 0 0.0 6 28.6 0 0.0 0 0.0 2 0.8
pil2b (A909) P2-B9 9 2.0 5 1.3 0 0.0 3 14.3 0 0.0 0 0.0 5 2.0
pil2b (unidentified) P2-BX 2 0.4 1 0.3 0 0.0 1 4.8 0 0.0 0 0.0 1 0.4
nss/srr/rogB2 negative N-0 6 1.3 4 1.0 2 5.9 0 0.0 1 0.9 0 0.0 5 2.0
nss/srr (COH1) N-1 80 17.9 70 18.2 9 26.5 0 0.0 33 28.7 7 14.6 39 15.3
nss/srr/rogB2 (NEM316) N-3 268 59.8 234 60.9 21 61.8 7 33.3 62 53.9 29 60.4 164 64.3
nss/srr/rogB2 (A909) N-9 94 21.0 76 19.8 2 5.9 14 66.7 19 16.5 12 25.0 47 18.4
rgf negative R-0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
rgf (COH1) R-1 75 16.7 70 18.2 2 5.9 2 9.5 33 28.7 7 14.6 32 12.5
rgf (515) R-5 233 52.0 188 49.0 30 88.2 10 47.6 48 41.7 24 50.0 146 57.3
rgf (A909) R-9 138 30.8 124 32.3 2 5.9 9 42.9 34 29.6 17 35.4 75 29.4
rgf atypical/unidentified R-X 2 0.4 2 0.5 0 0.0 0 0.0 0 0.0 0 0.0 2 0.8